Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Debt Ratio of 0.13 for Q1 2026, down 10.06% year-over-year from 0.15 in Q1 2025, and up 5.25% quarter-over-quarter from 0.13 in Q4 2025.
Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Debt Ratio for 9 consecutive years, with 0.13 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio fell 10.06% year-over-year to 0.13; the TTM figure through Mar 2026 stood at 0.13 (down 10.06% YoY), while the FY2025 annual figure was 0.13, down 26.93% from the prior year.
- Debt Ratio climbed to 0.13 in Q1 2026 per AKBA's latest filing, from 0.13 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.37 in Q2 2022 and bottomed at 0.13 in Q4 2025.
- Historically, Debt Ratio has averaged 0.18 across 5 years, with a median of 0.17 in 2024.
- Annual changes were most pronounced in 2022 — Debt Ratio surged 133.9% — and 2023, when it slumped 54.8%.
- Akebia Therapeutics' Debt Ratio stood at 0.19 in 2022, then declined by 22.68% to 0.14 in 2023, then climbed by 22.2% to 0.18 in 2024, then decreased by 26.93% to 0.13 in 2025, then gained by 5.25% to 0.13 in 2026.
- Business Quant data shows AKBA's Debt Ratio at 0.13 in Q1 2026, 0.13 in Q4 2025, and 0.13 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -0.13 |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.42 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.32 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.38 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.29 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.12 |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 0.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.21 |
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.13 |
| Dec 31, 2023 | 0.14 |
| Sep 30, 2023 | 0.18 |
| Jun 30, 2023 | 0.17 |
| Mar 31, 2023 | 0.18 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.30 |
| Jun 30, 2022 | 0.37 |
| Mar 31, 2022 | 0.18 |
| Dec 31, 2021 | 0.18 |
| Sep 30, 2021 | 0.16 |